Colgate-Palmolive (NYSE:CL) Releases Earnings Results, Beats Estimates By $0.05 EPS

Colgate-Palmolive (NYSE:CL) released its quarterly earnings data on Friday. The company reported $0.74 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.69 by $0.05, MarketWatch Earnings reports. Colgate-Palmolive had a net margin of 15.86% and a return on equity of 942.99%. The company had revenue of $3.90 billion during the quarter, compared to the consensus estimate of $3.78 billion. During the same period last year, the firm earned $0.72 EPS. Colgate-Palmolive’s revenue for the quarter was up .8% on a year-over-year basis.

NYSE:CL opened at $77.20 on Friday. The company has a 50 day moving average price of $73.69 and a 200-day moving average price of $71.47. Colgate-Palmolive has a 1-year low of $58.49 and a 1-year high of $77.46. The firm has a market cap of $66.12 billion, a price-to-earnings ratio of 26.35, a price-to-earnings-growth ratio of 4.78 and a beta of 0.60. The company has a debt-to-equity ratio of 21.51, a current ratio of 0.96 and a quick ratio of 0.66.

The company also recently announced a quarterly dividend, which will be paid on Friday, August 14th. Stockholders of record on Monday, July 20th will be issued a dividend of $0.44 per share. This represents a $1.76 annualized dividend and a dividend yield of 2.28%. The ex-dividend date of this dividend is Friday, July 17th. Colgate-Palmolive’s dividend payout ratio (DPR) is 62.19%.

In other Colgate-Palmolive news, Director Michael B. Polk sold 3,115 shares of Colgate-Palmolive stock in a transaction on Wednesday, May 13th. The shares were sold at an average price of $68.08, for a total transaction of $212,069.20. Following the sale, the director now owns 20,622 shares of the company’s stock, valued at approximately $1,403,945.76. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 0.78% of the stock is currently owned by company insiders.

CL has been the topic of a number of analyst reports. Deutsche Bank lifted their target price on shares of Colgate-Palmolive from $73.00 to $75.00 and gave the stock a “hold” rating in a research report on Monday, July 27th. TheStreet lowered shares of Colgate-Palmolive from a “b” rating to a “c+” rating in a research note on Friday, May 1st. Credit Suisse Group reaffirmed a “sell” rating and set a $67.00 target price on shares of Colgate-Palmolive in a research note on Monday, May 4th. SunTrust Banks lifted their price target on shares of Colgate-Palmolive from $75.00 to $80.00 and gave the company a “buy” rating in a research report on Friday, May 15th. Finally, Stifel Nicolaus lifted their price target on shares of Colgate-Palmolive from $72.00 to $75.00 and gave the company a “buy” rating in a research report on Monday, May 4th. Three analysts have rated the stock with a sell rating, five have given a hold rating and seven have given a buy rating to the stock. The company has an average rating of “Hold” and an average price target of $74.92.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.

Read More: Which market index is the best?

Earnings History for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with's FREE daily email newsletter.